L Morera, M Lübbert, M Jung - Clinical epigenetics, 2016 - Springer
The term epigenetics is defined as heritable changes in gene expression that are not due to alterations of the DNA sequence. In the last years, it has become more and more evident …
JA Simon, RE Kingston - Nature reviews Molecular cell biology, 2009 - nature.com
Polycomb proteins form chromatin-modifying complexes that implement transcriptional silencing in higher eukaryotes. Hundreds of genes are silenced by Polycomb proteins …
E Viré, C Brenner, R Deplus, L Blanchon, M Fraga… - Nature, 2006 - nature.com
The establishment and maintenance of epigenetic gene silencing is fundamental to cell determination and function. The essential epigenetic systems involved in heritable …
Polycomb group proteins are essential for early development in metazoans, but their contributions to human development are not well understood. We have mapped the …
Chromatin alterations have been associated with all stages of tumour formation and progression. The best characterized are epigenetically mediated transcriptional-silencing …
AP Bracken, N Dietrich, D Pasini… - Genes & …, 2006 - genesdev.cshlp.org
The Polycomb group (PcG) proteins form chromatin-modifying complexes that are essential for embryonic development and stem cell renewal and are commonly deregulated in cancer …
A Sparmann, M Van Lohuizen - Nature Reviews Cancer, 2006 - nature.com
Polycomb group (PcG) proteins are epigenetic gene silencers that are implicated in neoplastic development. Their oncogenic function might be associated with their well …
AP Bracken, D Kleine-Kohlbrecher… - Genes & …, 2007 - genesdev.cshlp.org
The p16INK4A and p14ARF proteins, encoded by the INK4A-ARF locus, are key regulators of cellular senescence, yet the mechanisms triggering their up-regulation are not well …
J Tan, X Yang, L Zhuang, X Jiang, W Chen… - Genes & …, 2007 - genesdev.cshlp.org
Polycomb-repressive complex 2 (PRC2)-mediated histone methylation plays an important role in aberrant cancer gene silencing and is a potential target for cancer therapy. Here we …